SV Life Sciences Advisers LLP

https://www.svlsa.com

SV Life Sciences is a leading, international life sciences venture capital firm. SVLS affiliated funds have been investing in life sciences companies since the early 1980s and the Firm closed its first dedicated life sciences fund in 1994. SVLS’ team of 32 professionals is organized according to experience and specialization into three practice areas: Biotechnology/Biopharmaceuticals, Medical Devices/Instrumentation, and Healthcare Services/Healthcare IT. These individuals’ diverse and complementary skill sets and experiences enable SVLS to tailor an investment team for almost any life science business. Typically, SVLS recruits operating executives, called Venture Partners, who have distinguished careers in the life sciences fields and can bring extensive operating expertise to the SVLS portfolio of investments. They assist in sourcing, building and exiting investments successfully. In some cases, these individuals are promoted to serve as Partners and/or Managing Partners within the Firm. SVLS employs a close symbiosis between operating and financial professionals which has led to significant success over five investment funds. SVLS has offices in Boston, London and San Francisco. *

	Start	2005-08-02 existent
	End	2017-04-10 renamed
	Group	SV Health Investors (Group)
	Today	SV Health Investors LLP
	Successor	SV Health Investors LLP
	Industry	fund, biotech / life sciences

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	71 Kingsway
	City	WX2B London
	Tel	+44-20-7421-7070
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Kesios Therapeutics Ltd.. (12/2/15). "Press Release: Kesios Therapeutics Raises £19 Million in Series A Financing. Builds Management Team Led by Dr. Paolo Paoletti as CEO". London.

		Record changed: 2018-10-30